STAT+: Lawmakers introduce bill to require drugmakers to provide key info to both FDA and U.S. Patent Office
Amid concerns over monopolies held by drugmakers, a bipartisan group of lawmakers introduced a bill…
Category: drug prices
.jpg)
STAT+: White House touts efforts to stem cancer drug shortages
WASHINGTON — The White House says it’s working to end shortages of three key generic…
Is there a path forward for PEPFAR?
You’re reading the web edition of D.C. Diagnosis. Sign up here to receive this newsletter in your…
Opinion: How the drug price negotiation program could affect Medicare Part D beneficiaries
After the recent announcement of the first 10 drugs selected for Medicare price negotiation, much…
A new House health package & hospitals’ new site-neutral talking points
You’re reading the web edition of D.C. Diagnosis. Sign up here to receive this newsletter in your…
STAT+: Why the drug industry’s opaque warnings on price negotiations fall short
Ever since Medicare was given power to negotiate prices for certain medicines, the pharmaceutical industry…
STAT+: South Africa was forced into ‘one-sided’ deals with Covid-19 vaccine suppliers, contracts reveal
South Africa was “bullied” into signing one-sided contracts with Covid-19 vaccine suppliers that forced the…
.jpg)
Opinion: What does ‘bona fide competition’ actually mean in the biologics market?
On Aug. 29, Medicare released its highly anticipated list of 10 therapies for which it…
STAT+: Astellas withdraws lawsuit after evading Medicare drug price negotiations
WASHINGTON — Astellas was so sure that one of its drugs was going to be…
STAT+: FTC settles with Amgen over $28 billion deal for Horizon
After months of legal sparring, Amgen and Horizon Therapeutics settled a lawsuit with the U.S….
STAT+: The curious case of J&J’s Stelara, the unluckiest drug on Medicare’s list
WASHINGTON — Ninety-eight days may end up costing Johnson & Johnson. When Medicare this week…
STAT+: Winners and losers from Medicare’s list of drugs subject to price negotiation
On Tuesday morning, the U.S. Department of Health and Human Services unveiled its long-awaited list…
Here are the 10 drugs that will be up first for Medicare price negotiation
WASHINGTON — Medicare on Tuesday announced the first 10 drugs selected for a new drug…
STAT+: AstraZeneca sues to immediately stop Medicare drug price negotiation program
WASHINGTON — AstraZeneca is the sixth drug maker to pile on a legal challenge to…
Abortion policy in the spotlight, DeSantis’ importation showdown, and new price hike analysis
You’re reading the web edition of D.C. Diagnosis. Sign up here to receive this newsletter…
Mid-year drug price hikes are back despite Inflation Reduction Act
It’s almost a tradition. At the start and halfway points of each year, many pharmaceutical…
STAT+: Ron DeSantis wants to import drugs from Canada. Biden’s FDA just blasted his plan
WASHINGTON — Florida governor and presidential hopeful Ron DeSantis has ballyhooed a high-profile plan to…
STAT+: Pharmalittle: Roche data on immunotherapy accidentally released; Novo Nordisk hires Thermo Fisher to manufacture Wegovy
Hello and happy Wednesday from STAT’s London outpost, with Andrew Joseph here filling in for…
STAT+: Eli Lilly CEO donates big to Mike Pence presidential super PAC
WASHINGTON — David Ricks, who leads Eli Lilly, made a major early donation to a…
STAT+: Medicare wants to improve Alzheimer’s care, but sidesteps drug prices
WASHINGTON — Medicare announced today a pilot program aimed at improving dementia care and reducing…
STAT+: ‘It’s like Groundhog Day’: The cancer drug shortage isn’t new — and neither are the solutions
A young girl, maybe 5 or 6 years old, had come into Yoram Unguru’s clinic…
‘Tantamount to extortion:’ Merck sues U.S. government over Medicare negotiation program
WASHINGTON — Merck on Tuesday sued to stop the federal government from implementing a new…
STAT+: Medicare taps acting official to head up its new drug price negotiations
WASHINGTON — Medicare has chosen a Center for Medicare and Medicaid Innovation official to temporarily…
How the drug industry uses fear of fentanyl to extract more profit from naloxone
As the U.S. drug crisis has accelerated, the pharmaceutical industry has jumped into action —…
STAT+: Congressional Medicare advisers warn of higher drug prices, despite new price negotiation
WASHINGTON — Despite the pharmaceutical industry’s loud complaints to the contrary, the new law directing…
We finally have new drugs for sickle cell disease. Why are so few patients taking them?
At first, Lena Harvey didn’t realize anything had changed. She just started doing strange, unexpected…
With a promising new plan to pay for pricey cures, two states set out to eliminate hepatitis C. But cost hasn’t been the biggest problem
WASHINGTON — For nearly a decade, many experts assumed the biggest obstacle to eliminating hepatitis…
STAT+: New Senate proposal to lower insulin prices would let drugmakers lock in their current profits
WASHINGTON — A new proposal that senators claim would fix insulin pricing would actually allow…
STAT+: Pfizer to refund $290,000 to consumers in four states over misleading copay couponds
Amid controversy over the use of patient coupons, Pfizer has agreed to refund $290,000 to…
STAT+: Key senators eye new, more ambitious legislation to lower insulin prices
WASHINGTON — Key Senate lawmakers have begun writing a bipartisan bill that would cap the prices…
Q&A: The CEO of the Alzheimer’s Association on the approval of Aduhelm — and why critics should stop dwelling on the decision
Harry Johns is ready to stop talking about whether or not the Food and Drug…
Opinion: If 2021 is to be the year of U.S. drug price controls, how should biopharma companies respond?
As the Biden administration assumes leadership in Washington and former President Donald Trump’s most-favored nation…
Sensing an advantage, Democrats dare Trump to talk drug prices during State of the Union
WASHINGTON — Democratic lawmakers aren’t likely to cheer for many lines in President Trump’s State…